# Ginkgo Bioworks Holdings, Inc.: Form 8-K, filed Nov 8, 2023

- Company: [Ginkgo Bioworks Holdings, Inc.](/companies/dna.md) (CIK 1830214)
- Form: 8-K
- Filed: 2023-11-08
- Accepted by EDGAR: Nov 8, 2023, 17:02 ET
- Period: 2023-11-08
- Accession: 0001628280-23-037916
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1830214/000162828023037916/dna-20231108.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1830214/000162828023037916/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1830214/000162828023037916/dna-20231108.htm

Filed Nov 8, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-037916. Last ingested by Listed: Oct 29, 2026, 16:07 ET. No prices; not investment advice.